We are monitoring the impact of COVID-19 on Europe Stem Cell Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 11500
Share on
Share on

Europe Stem Cell Therapy Market Research Report – Segmented By Type, Application, Cell Source, End-Users and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 11500
Pages: 90

Europe Stem Cell Therapy Market Size (2021 to 2026)

The size of the European stem cell therapy market is estimated to register a CAGR of 10.46% between 2021 to 2026.

The European stem cell therapy market is expected to be primarily driven by the factors such as a growing number of biomedical research efforts and a growing focus on the treatment for neurological disorders. Evolving induced pluripotent stem cell lines in the European region are contributing to the regional market growth. Also, rising socio-ethical issues involved with embryonic stem cells and adoption of iPSCs as alternatives are most likely to evolve the European stem cell therapy market growth. Moreover, European regional companies are developing innovative therapeutic technologies that can boost market growth. Due to the advancement of contemporary health research, stem cells play an important role in researching disease prevalence, drug discovery, and the development of innovative regenerative medicines.

On the other hand, private and government organizations boosting investment and funding for better hospital infrastructures encourages the stem cell therapy market. Personalized drugs are becoming increasingly common, which is fuelling the European stem cell therapy market growth. Researchers are designing innovative sourcing approaches that can also be used to develop personalized drugs. Companies are undertaking fundamental science and preclinical studies to assess stem cells' regenerative capability in the treatment of personalized disorders. For example, iPSC therapies are created by taking a tiny amount of a patient's blood or skin cells and reprogramming them to shape new cells and tissue for transplant. As a result, future customized therapies can be produced by the use of these cells.

However, stringent government regulations on stem cell therapies are expected to restrain the European stem cell therapy market growth. Also, a lack of awareness about stem cell therapy in underdeveloped countries is considered to be one of the growth restrains factors for the market growth. Technical constraints associated with production scale-up and a scarcity of trained practitioners are regarded as hindrances to market growth. Furthermore, the difficulties of collecting and storing somatic cell stem cells limit the European stem cell therapy market growth.

Impact of COVID-19 on the Europe Stem Cell Therapy Market:

The global pandemic COVID-19 had affected the market sector in different ways. The European regional market had negatively impacted due to the limited exchange activities in the region. Europe had implemented the lockdown to control disease transmission. The prohibition on transportation had disrupted the supply chain.

However, post to the uplift of lockdown, the market has recorded significant growth due to the rising demand for personalized treatments. Companies are focusing on developing therapies for reducing different stress associated with COVID-19.  In October, NoveCite and Novellus Therapeutics Limited have formed a collaboration to produce and commercialize NoveCite iPSCs to treat COVID-19-associated Acute Respiratory Distress Syndrome (ARDS).

This research report on the Europe stem cell therapy market has been segmented and sub-segmented based on the following categories.

 By Type:

  • Allogeneic
  • Autologous

By Application:

  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cardiovascular Diseases
  • Surgeries
  • Gastrointestinal Diseases
  • Other Applications

By Cell Source:

  • Adipose Tissue-Derived Mesenchymal Stem Cells
  • Bone Marrow-Derived Mesenchymal Stem Cells
  • Cord Blood/Embryonic Stem Cells
  • Other Cell Sources

By End User:

  • Hospitals
  • Clinics

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, Stem cell research is one of the most promising fields of medicine in the twenty-first century, with the potential to revolutionize the way we treat disorders such as degenerative diseases, for which there are actually few effective drugs. The European stem cell market is one of the most rapidly growing markets. The European regional stem cell therapy market recorded significant growth in 2020.

In the regional stem cell therapy market, the United Kingdom witnessed significant growth over the forecast period. The market growth is attributed as Stem cell therapies are gaining momentum as a potential cure for diseases such as Parkinson's disease, Alzheimer's disease, cancer, and diabetes, which affect a significant proportion of the population in the United Kingdom. As per the Global Cancer Observatory, more than 446,900 new cancer cases were registered in the United Kingdom in 2018. Furthermore, cancers such as breast, prostate, eye, and lung are among the most commonly diagnosed cancers in the country.

Germany is one of the promising countries in Europe, with a rapidly growing stem cell therapy market growth over the forecast period. The growing geriatric population, adoption of innovative therapeutic technologies, and supportive government funds for the healthcare infrastructure are most likely to encourage the stem cell therapy market growth in the country.

KEY MARKET PLAYERS:

Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate SRL, JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., and Allosource are a few of the companies playing a promising role in the European stem cell therapy market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1.  By Type
      1. Allogeneic Stem Cell Therapy
      2. Autologous
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    2. By Application
      1. Musculoskeletal Disorders
      2. Wounds and Injuries
      3. Cardiovascular Diseases
      4. Surgeries
      5. Gastrointestinal Diseases
      6. Other Applications
      7. Y-o-Y Growth Analysis, By Application
      8. Market Attractiveness Analysis, By Application
      9. Market Share Analysis, By Application
    3. By Cell Source
      1. Adipose Tissue-Derived Mesenchymal Stem Cells
      2. Bone Marrow-Derived Mesenchymal Stem Cells
      3. Cord Blood/Embryonic Stem Cells
      4. Other Cell Sources
      5. Y-o-Y Growth Analysis, By Cell Source
      6. Market Attractiveness Analysis, By Cell Source
      7. Market Share Analysis, By Cell Source
    4. By End-User
      1. Hospitals
      2. Clinics
      3. Y-o-Y Growth Analysis, By End-User
      4. Market Attractiveness Analysis, By End-User
      5. Market Share Analysis, By End-Use
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Component
        3. By Delivery
        4. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Component
        3. By Delivery
        4. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Component
        3. By Delivery
        4. By End-User
    2. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
      7. Rest of Europe
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Components and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Osiris Therapeutics, Inc.
      1. Overview
      2. Component Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. MEDIPOST Co., Ltd.
    3. Anterogen Co., Ltd.
    4. Pharmicell Co., Ltd.
    5. Holostem Terapie Avanzate SRL
    6. JCR Pharmaceuticals Co., Ltd.
    7. NuVasive, Inc.
    8. RTI Surgical, Inc.
    9. Allosource
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Component Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Europe Stem Cell Therapy Market, By Type, From 2021 to 2026 (USD Million)
  2. Europe Allogeneic Stem Cell Therapy Market, By Region, From 2021 to 2026 (USD Million)
  3. Europe Autologous Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe Stem Cell Therapy Market, By Application, From 2021 to 2026 (USD Million)
  5. Europe Musculoskeletal Disorders Market, By Region, From 2021 to 2026 (USD Million)
  6. Europe Wounds and Injuries Market, By Region, From 2021 to 2026 (USD Million)
  7. Europe Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Million)
  8. Europe Surgeries Market, By Region, From 2021 to 2026 (USD Million)
  9. Europe Gastrointestinal Diseases Market, By Region, From 2021 to 2026 (USD Million)
  10. Europe Other Applications Market, By Region, From 2021 to 2026 (USD Million)
  11. Europe Stem Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Million)
  12. Europe Adipose Tissue-Derived Mesenchymal Stem Cells Market, By Region, From 2021 to 2026 (USD Million)
  13. Europe Bone Marrow-Derived Mesenchymal Stem Cells Market, By Region, From 2021 to 2026 (USD Million)
  14. Europe Cord Blood/Embryonic Stem Cells Market, By Region, From 2021 to 2026 (USD Million)
  15. Europe Other Cell Sources Market, By Region, From 2021 to 2026 (USD Million)
  16. Europe Stem Cell Therapy Market, By End User, From 2021 to 2026 (USD Million)
  17. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  18. Europe Clinics Market, By Region, From 2021 to 2026 (USD Million)
  19. U.K. Stem Cell Therapy Market, By Type, From 2021 to 2026 (USD Million)
  20. U.K. Stem Cell Therapy Market, By Application, From 2021 to 2026 (USD Million)
  21. U.K. Stem Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Million)
  22. U.K. Stem Cell Therapy Market, By End User, From 2021 to 2026 (USD Million)
  23. Germany Stem Cell Therapy Market, By Type, From 2021 to 2026 (USD Million)
  24. Germany Stem Cell Therapy Market, By Application, From 2021 to 2026 (USD Million)
  25. Germany Stem Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Million)
  26. Germany Stem Cell Therapy Market, By End User, From 2021 to 2026 (USD Million)
  27. France Stem Cell Therapy Market, By Type, From 2021 to 2026 (USD Million)
  28. France Stem Cell Therapy Market, By Application, From 2021 to 2026 (USD Million)
  29. France Stem Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Million)
  30. France Stem Cell Therapy Market, By End User, From 2021 to 2026 (USD Million)
  31. Italy Stem Cell Therapy Market, By Type, From 2021 to 2026 (USD Million)
  32. Italy Stem Cell Therapy Market, By Application, From 2021 to 2026 (USD Million)
  33. Italy Stem Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Million)
  34. Italy Stem Cell Therapy Market, By End User, From 2021 to 2026 (USD Million)
  35. Spain Stem Cell Therapy Market, By Type, From 2021 to 2026 (USD Million)
  36. Spain Stem Cell Therapy Market, By Application, From 2021 to 2026 (USD Million)
  37. Spain Stem Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Million)
  38. Spain Stem Cell Therapy Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample